Moreover, compared to control cells (CL), treatment of 786-O cells with visfatin (50 ng/mL) also induced a significant increase in Akt and p70S6K phosphorylation within 30 min and sustained activation for 8 h in human RCC 786-O cells (Figure 3D). This evidence concerns the gene RPS6KB1 and renal cell carcinoma.